Having shown that AF is able to reduce the development of OS metastases in an in vivo orthotopic model, and to increase the apoptotic marker, cleaved caspase-3, in AF treated subcutaneous tumours, we sought to elucidate the mechanism for the antimetastatic effects of AF in osteosarcoma. The gene discussed is CASP3; the disease is osteosarcoma.